2013 annual financial data

Sarepta Therapeutics 2013 Net margin

Sarepta Therapeutics 2013 net margin with verified reported values.

Direct answer

Net margin was -787.57%.

Operating income was -90,284,000 USD and net income was -111,985,000 USD.
Operating cash flow was -64,695,000 USD.

Get free Sarepta Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
14,219,000 USD
Operating income
-90,284,000 USD
Net income
-111,985,000 USD
Operating cash flow
-64,695,000 USD